Preclinical stage biotechnology company committed to the discovery and development of cutting-edge radiopharmaceuticals.
Focus-X Therapeutics is tracked in the Tech.eu funding database. Based in New Jersey, United States; active in Healthtech. Acquired by Full-Life Technologies in 2022. Data as of 23 Aug 2026.
